Insulet wins $452 mln US verdict against EOFlow in insulin pump secrets case
Medical device maker Insulet convinced a jury that Korean rival EOFlow owes it $452 million in damages for stealing trade ...
Insulet wins $452 million US verdict against EOFlow in insulin pump secrets case
Medical device maker Insulet convinced a jury that Korean rival EOFlow owes it $452 million in damages for stealing trade ...
medtechdive6d
Insulet awarded $452M in EOFlow patent fight
A jury found that competitor EOFlow and former executives misappropriated trade secrets for Insulet’s Omnipod insulin pumps.
FierceBiotech6d
Insulet nets $452M in damages from insulin pump rival EOFlow in trade secrets suit
The Massachusetts district court awarded Insulet a total of $452 million, including $170 million in compensation plus $282 ...
STAT5d
Insulet wins trade secret case against Korean insulin pump maker
Insulin pump maker Insulet won $452 million in its trade secret case against Korean rival EOFlow, the company announced on ...
pharmaphorum5d
Insulin pump firm Insulet wins $452m in trade secrets clash
The lawsuit revolved around Insulet's Omnipod tubeless insulin pump – used with continuous glucose monitors (CGMs) to create ...
Insulet Successfully Defends its Intellectual Property Against EOFlow Co. in U.S. District Court
Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its ...
Yahoo Finance6d
Insulet awarded $452M in EOFlow patent fight
A federal jury on Tuesday awarded Insulet $452 million in its patent skirmish with EOFlow over insulin patch pumps. The jury awarded Insulet $170 million in compensatory damages from EOFlow and an ...